NYSE:STVN Stevanato Group (STVN) Stock Price, News & Analysis €17.76 +0.43 (+2.49%) Closing price 03:59 PM EasternExtended Trading€17.77 +0.01 (+0.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Stevanato Group Stock (NYSE:STVN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Stevanato Group alerts:Sign Up Key Stats Today's Range€17.24▼€17.9350-Day Range€13.40▼€19.0352-Week Range€12.89▼€28.00Volume379,076 shsAverage Volume649,617 shsMarket Capitalization€5.38 billionP/E Ratio30.10Dividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology. In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers. Through its Networked Inspection Systems division, the company offers machine-vision inspection equipment designed to meet stringent quality standards and regulatory requirements. Stevanato’s manufacturing capabilities also extend into polymer primary packaging and high-precision molding, enabling a broader portfolio of container formats. Founded in 1949 and headquartered in Piombino Dese, Italy, Stevanato Group has expanded its footprint with manufacturing sites and engineering centers across Europe, North America, Latin America and Asia. Key production facilities are located in Italy, the United States, Brazil, Slovakia and China. This global presence allows the company to serve multinational pharmaceutical and biotech firms as well as contract development and manufacturing organizations (CDMOs). Under the leadership of Chief Executive Officer Paolo Dellachà, Stevanato Group emphasizes innovation, sustainability and digitalization in its operations. The company invests in research and development to advance containment materials, processing technologies and inspection automation. With a focus on environmental stewardship and patient safety, Stevanato continues to evolve its offerings to meet the dynamic needs of the life sciences sector.AI Generated. May Contain Errors. Read More Stevanato Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreSTVN MarketRank™: Stevanato Group scored higher than 61% of companies evaluated by MarketBeat, and ranked 359th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingStevanato Group has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageStevanato Group has only been the subject of 4 research reports in the past 90 days.Read more about Stevanato Group's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth17.65% Earnings GrowthEarnings for Stevanato Group are expected to grow by 17.65% in the coming year, from €0.68 to €0.80 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stevanato Group is 30.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.53.Price to Earnings Ratio vs. SectorThe P/E ratio of Stevanato Group is 30.10, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.73.Price to Earnings Growth RatioStevanato Group has a PEG Ratio of 1.64. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStevanato Group has a P/B Ratio of 3.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.29% of the float of Stevanato Group has been sold short.Short Interest Ratio / Days to CoverStevanato Group has a short interest ratio ("days to cover") of 1.58, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Stevanato Group has recently decreased by 16.07%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthN/A Dividend YieldStevanato Group does not currently pay a dividend.Dividend GrowthStevanato Group has only been increasing its dividend for 1 years.Dividend SustainabilityBased on earnings estimates, Stevanato Group will have a dividend payout ratio of 7.50% next year. This indicates that Stevanato Group will be able to sustain or increase its dividend. News and Social Media0.6 / 5News SentimentN/A Search Interest7 people have searched for STVN on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Stevanato Group insiders have not sold or bought any company stock.Percentage Held by InstitutionsStevanato Group has minimal institutional ownership at this time.Read more about Stevanato Group's insider trading history. Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. STVN Stock News HeadlinesStevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comStevanato Group SpA (STVN)May 10, 2026 | investing.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 20 at 1:00 AM | Brownstone Research (Ad)Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsMay 9, 2026 | finance.yahoo.comA Look At Stevanato Group’s (NYSE:STVN) Valuation After Its Recent Share Price ReboundMay 7, 2026 | finance.yahoo.comStevanato maintains 2026 guidance of €1.260B-€1.290B revenue as it targets RTU cartridge production in early 2027May 7, 2026 | msn.comStevanato Group Files Form 6-K Detailing Q1 2026 Results PresentationMay 7, 2026 | tipranks.comStevanato Group S.p.A. (STVN) Q1 2026 Earnings Call TranscriptMay 7, 2026 | seekingalpha.comSee More Headlines STVN Stock Analysis - Frequently Asked Questions How have STVN shares performed this year? Stevanato Group's stock was trading at €20.11 on January 1st, 2026. Since then, STVN shares have decreased by 11.7% and is now trading at €17.76. How were Stevanato Group's earnings last quarter? Stevanato Group S.p.A. (NYSE:STVN) posted its earnings results on Friday, May, 8th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by $0.01. The business's revenue was up 6.6% compared to the same quarter last year. Read the conference call transcript. When did Stevanato Group IPO? Stevanato Group (STVN) raised $720 million in an initial public offering (IPO) on Friday, July 16th 2021. The company issued 32,000,000 shares at $21.00-$24.00 per share. Who are Stevanato Group's major shareholders? Stevanato Group's top institutional shareholders include Conestoga Capital Advisors LLC (2.80%), Ranger Investment Management L.P. (0.42%), Riverbridge Partners LLC (0.22%) and Peregrine Capital Management LLC (0.15%). How do I buy shares of Stevanato Group? Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Stevanato Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stevanato Group investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Fortinet (FTNT), Antero Resources (AR), CrowdStrike (CRWD), Walt Disney (DIS) and onsemi (ON). Company Calendar Last Earnings5/08/2026Today5/20/202646th Annual William Blair Growth Stock Conference6/02/2026Jefferies Global Healthcare Conference 20266/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, STVN's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNYSE:STVN CIK1849853 Webwww.stevanatogroup.com Phone39049931811FaxN/AEmployees6,010Year Founded1949Profitability EPS (Trailing Twelve Months)€0.59 Trailing P/E Ratio30.10 Forward P/E Ratio26.12 P/E Growth1.64Net Income€158.21 million Net Margins11.76% Pretax Margin15.97% Return on Equity10.27% Return on Assets6.08% Debt Debt-to-Equity Ratio0.21 Current Ratio1.63 Quick Ratio1.11 Sales & Book Value Annual Sales€1.34 billion Price / Sales4.01 Cash Flow€0.88 per share Price / Cash Flow20.17 Book Value€5.92 per share Price / Book3.00Miscellaneous Outstanding Shares302,840,000Free FloatN/AMarket Cap€5.38 billion OptionableOptionable Beta0.75 Social Links The 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:STVN) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredThe $700 billion buy signal most investors are completely ignoringAmazon, Google, Meta, and Microsoft have committed $700 billion to AI infrastructure this year - more capital ...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stevanato Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
